Dr. Brian A. Smith, MD
Family Medicine (Family Medicine Physician)
460 Wilson Ave, First Floor
Versailles, KY 40383
Who else practices at this address →
Woodford County is a federal mental health shortage area. About shortage areas
- Medicare participating
At a glance
- Medical school
- Duke University School of Medicine (2000)
- Years since graduation
- 26
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 469
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2000Medical school: Duke University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Family Medicine Physician primary
KY license 40454 -
Emergency Medicine Physician
KY license 40454
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Baptist Health Lexington Lexington, KY
- Saint Joseph East Lexington, KY
- Frankfort Regional Medical Center Frankfort, KY
- Bourbon Community Hospital Paris, KY
- Bluegrass Community Hospital Versailles, KY
Medical groups
- Hospital Medicine Services of Tennessee PC (162 clinicians)
- Versailles Family Medicine, PLLC (7 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 469
- Services billed
- 2,088
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Insertion of needle into vein for collection of blood sample | 648 | 306 |
| Established patient office or other outpatient visit, 30-39 minutes | 554 | 245 |
| Established patient office or other outpatient visit, 20-29 minutes | 545 | 242 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 299 | 118 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 213 | 213 |
| Injection of drug or substance under skin or into muscle | 210 | 47 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 145 | 34 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 143 | 72 |
| Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | 143 | 57 |
| Testing for presence of drug, read by direct observation | 134 | 60 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 18 companies reported 48 payments worth $688 in total to this clinician.
| AbbVie Inc. | $219 |
|---|---|
| Pfizer Inc. | $61.53 |
| Indivior Inc. | $54.74 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $43.41 |
| Takeda Pharmaceuticals U.S.A., Inc. | $34.48 |
| EMD Serono, Inc. | $32.76 |
| Ipsen Biopharmaceuticals, Inc | $26.47 |
| Lundbeck LLC | $24.62 |
| Food and Beverage | $688 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 9 industry-funded studies in 2025, from 6 companies. The companies reported $583,467 in research payments for these studies, mostly to the institutions running them.
- WEV-MVA-002
Bavarian Nordic A/s - A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥60 Years of Age
ModernaTX, Inc. · Completed · NCT05127434 - Roche Cancer Screening Collection Study
Genentech, Inc. - A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19
ModernaTX, Inc. · Completed · NCT05815498 - A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Effect of AZD0780 on Major Adverse Cardiovascular Events in Patients with Established Atherosclerotic Cardiovascular Diseas…
AstraZeneca Pharmaceuticals LP - A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults
ModernaTX, Inc. · Completed · NCT05827926 - BAY 948862, A parallel-group treatment, Phase 2, double-blind, three-arm study to assess efficacy and safety of finerenone plus empagliflozin compared with either finerenone or empagliflozin in partic
Bayer HealthCare Pharmaceuticals Inc. - A phase 3,global,randomized,modified double blind,placebo controlled,study to evaluate the efficacy,immunogenicity,and safety of IVX A12,a respiratory syncytial virus RSV and human metapneumovirus hMPV virus like part…
AstraZeneca Pharmaceuticals LP - A phase iii, open-label, randomized, controlled, multi-country study t
GlaxoSmithKline, LLC.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.